Dysfunctional phenotype of systemic and pulmonary regulatory T cells associate with lethal COVID-19 cases

Immunology. 2023 Apr;168(4):684-696. doi: 10.1111/imm.13603. Epub 2022 Nov 23.

Abstract

Severe cases of COVID-19 present hyperinflammatory condition that can be fatal. Little is known about the role of regulatory responses in SARS-CoV-2 infection. In this study, we evaluated the phenotype of regulatory T cells in the blood (peripheral blood mononuclear cell) and the lungs (broncho-alveolar) of adult patients with severe COVID-19 under invasive mechanical ventilation. Our results show important dynamic variation on Treg cells phenotype during COVID-19 with changes in number and functional parameters from the day of intubation (Day 1 of intensive care unit admission) to Day 7. We observed that compared with surviving patients, non-survivors presented lower numbers of Treg cells in the blood. In addition, lung Tregs of non-survivors also displayed higher PD1 and lower FOXP3 expressions suggesting dysfunctional phenotype. Further signs of Treg dysregulation were observed in non-survivors such as limited production of IL-10 in the lungs and higher production of IL-17A in the blood and in the lungs, which were associated with increased PD1 expression. These findings were also associated with lower pulmonary levels of Treg-stimulating factors like TNF and IL-2. Tregs in the blood and lungs are profoundly dysfunctional in non-surviving COVID-19 patients.

Keywords: COVID-19; invasive mechanical ventilation; regulatory T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • Lung / metabolism
  • Phenotype
  • SARS-CoV-2 / metabolism
  • T-Lymphocytes, Regulatory* / metabolism

Substances

  • Forkhead Transcription Factors